JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.51B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$818M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$596M |
| 4 |
Eaton
ETN
|
+$577M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$557M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Du Pont De Nemours E I
DD
|
+$1.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$727M |
| 3 |
Starbucks
SBUX
|
+$679M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$565M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$458M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.54% |
| 2 | Financials | 14.6% |
| 3 | Technology | 12.1% |
| 4 | Healthcare | 9.76% |
| 5 | Consumer Discretionary | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CTR
4401
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
| $26K | ﹤0.01% |
420
| – | – |
2015 Q3
8 quarters
|
|
|
LEJU
4402
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
| $26K | ﹤0.01% |
1,492
+1,158
| +347% | +$19K |
2017 Q2
1 quarter
|
|
4403
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $26K | ﹤0.01% |
20,860
+4,200
| +25% | +$5.37K |
2016 Q4
3 quarters
|
|
4404
Ardmore Shipping
ASC
$775M
| $25K | ﹤0.01% |
+3,000
| New | +$23.3K |
2017 Q3
0 quarters
|
|
4405
DELISTED
WW International
WW
| $25K | ﹤0.01% |
574
-20,548
| -97% | -$853K |
2016 Q2
5 quarters
|
|
|
CBB.PRB
4406
DELISTED
Cincinnati Bell Inc. DEP SHS
CBB.PRB
| $25K | ﹤0.01% |
500
| – | – |
2015 Q4
7 quarters
|
|
4407
Adamas Trust
ADAM
$700M
| $24K | ﹤0.01% |
963
-4,822
| -83% | -$121K |
2015 Q3
8 quarters
|
|
|
SNMP
4408
DELISTED
Evolve Transition Infrastructure LP
SNMP
| $24K | ﹤0.01% |
77
-2,749
| -97% | -$896K |
2015 Q4
7 quarters
|
|
|
AMRB
4409
DELISTED
American River Bankshares
AMRB
| $24K | ﹤0.01% |
1,701
-6,242
| -79% | -$85.5K |
2017 Q1
2 quarters
|
|
|
EOCC
4410
DELISTED
Enel Generacion Chile S.A.
EOCC
| $24K | ﹤0.01% |
935
-100
| -10% | -$2.41K |
2015 Q4
7 quarters
|
|
|
SYNT
4411
DELISTED
Syntel Inc
SYNT
| $24K | ﹤0.01% |
1,240
-306
| -20% | -$5.59K |
2014 Q1
14 quarters
|
|
4412
Forum Energy Technologies
FET
$885M
| $23K | ﹤0.01% |
73
-142
| -66% | -$38.1K |
2016 Q4
3 quarters
|
|
4413
Geron
GERN
$790M
| $23K | ﹤0.01% |
10,585
| – | – |
2014 Q4
11 quarters
|
|
|
GLCN
4414
DELISTED
VanEck China Growth Leaders ETF
GLCN
| $23K | ﹤0.01% |
500
| – | – |
2017 Q2
1 quarter
|
|
|
JONE
4415
DELISTED
Jones Energy, Inc.
JONE
| $23K | ﹤0.01% |
597
| – | – |
2014 Q3
12 quarters
|
|
|
ARLZ
4416
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
| $23K | ﹤0.01% |
10,587
+10,179
| +2,495% | +$13.6K |
2016 Q4
3 quarters
|
|
4417
American Superconductor
AMSC
$1.3B
| $22K | ﹤0.01% |
5,110
+4,087
| +400% | +$15.9K |
2015 Q4
7 quarters
|
|
4418
CSP Inc
CSPI
$74.7M
| $22K | ﹤0.01% |
+4,000
| New | +$20.8K |
2017 Q3
0 quarters
|
|
4419
Invesco S&P 500 Equal Weight Utilities ETF
RSPU
$505M
| $22K | ﹤0.01% |
500
| – | – |
2017 Q2
1 quarter
|
|
4420
Swiss Helvetia Fund
SWZ
$74.2M
| $22K | ﹤0.01% |
1,763
| – | – |
2015 Q4
7 quarters
|
|
4421
Invesco Trust Investment Grade Municipals
VGM
$489M
| $22K | ﹤0.01% |
1,600
| – | – |
2015 Q4
7 quarters
|
|
4422
State Street SPDR S&P Retail ETF
XRT
$404M
| $22K | ﹤0.01% |
530
-534,456
| -100% | -$21.5M |
2013 Q2
17 quarters
|
|
4423
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $22K | ﹤0.01% |
+335
| New | +$27.4K |
2017 Q3
0 quarters
|
|
4424
Inovio Pharmaceuticals
INO
$108M
| $21K | ﹤0.01% |
274
+34
| +14% | +$2.53K |
2014 Q3
12 quarters
|
|
4425
IRIDEX
IRIX
$14.5M
| $21K | ﹤0.01% |
2,224
-833
| -27% | -$7.58K |
2017 Q1
2 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2017 Portfolio in Review
As of Q3 2017, JP Morgan Chase held 5,458 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2017 filing shows 501 new, 2,053 increased, 1,909 reduced and 470 closed positions. Its largest new stake was JBG SMITH: 3,403,127 shares worth $116M. The largest sale was Du Pont De Nemours E I, an estimated $1.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q3 2017 buy was JBG SMITH: 3,403,127 shares worth $116M.
- JP Morgan Chase added most to DuPont de Nemours in Q3 2017, an estimated $1.51B increase.
- JP Morgan Chase's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $727M.
- JP Morgan Chase fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.4B.
- JP Morgan Chase's ten largest holdings make up 18% of its $453B portfolio in Q3 2017.
- JP Morgan Chase opened 501 new positions and closed 470 in Q3 2017.
- JP Morgan Chase's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.